Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series
Autonomix Medical (NASDAQ: AMIX), a medical device company focused on innovative technologies for diagnosing and treating nervous system diseases, has announced its participation in the Virtual Investor Closing Bell Series on Wednesday, July 24, 2024, at 4:00 PM ET. During this event, CEO Brad Hauser will provide a corporate overview and business outlook.
The event will feature a moderated discussion and allow investors to submit live questions. Autonomix will address as many questions as possible within the allotted time. A live video webcast will be available on the company's website, with a replay accessible for 90 days following the event.
Autonomix Medical (NASDAQ: AMIX), un'azienda di dispositivi medici focalizzata su tecnologie innovative per la diagnosi e il trattamento delle malattie del sistema nervoso, ha annunciato la sua partecipazione alla Virtual Investor Closing Bell Series mercoledì 24 luglio 2024, alle 16:00 ET. Durante questo evento, il CEO Brad Hauser fornirà una panoramica aziendale e le prospettive di business.
L'evento presenterà una discussione moderata e permetterà agli investitori di inviare domande in diretta. Autonomix affronterà quante più domande possibile entro il tempo assegnato. Una webcast video in diretta sarà disponibile sul sito web dell'azienda, con una registrazione accessibile per 90 giorni dopo l'evento.
Autonomix Medical (NASDAQ: AMIX), una empresa de dispositivos médicos centrada en tecnologías innovadoras para diagnosticar y tratar enfermedades del sistema nervioso, ha anunciado su participación en la Virtual Investor Closing Bell Series el miércoles 24 de julio de 2024, a las 16:00 ET. Durante este evento, el CEO Brad Hauser proporcionará una visión general de la empresa y una perspectiva comercial.
El evento contará con una discusión moderada y permitirá a los inversores enviar preguntas en vivo. Autonomix abordará tantas preguntas como sea posible dentro del tiempo asignado. Una transmisión de video en vivo estará disponible en el sitio web de la empresa, con una repetición accesible por 90 días después del evento.
Autonomix Medical (NASDAQ: AMIX)는 신경계 질환을 진단하고 치료하기 위한 혁신적인 기술에 중점을 둔 의료기기 회사로, 2024년 7월 24일 수요일 오후 4시 ET에 Virtual Investor Closing Bell Series에 참여한다고 발표했습니다. 이 이벤트에서는 CEO Brad Hauser가 기업 개요 및 비즈니스 전망을 제공할 것입니다.
이 이벤트는 진행된 토론을 특징으로 하며, 투자자들이 실시간 질문을 제출할 수 있도록 합니다. Autonomix는 정해진 시간 안에 가능한 많은 질문에 답변할 것입니다. 회사 웹사이트에서는 생중계 비디오 웹캐스트가 제공되며, 이벤트 후 90일 동안 재생할 수 있습니다.
Autonomix Medical (NASDAQ: AMIX), une entreprise de dispositifs médicaux axée sur des technologies innovantes pour le diagnostic et le traitement des maladies du système nerveux, a annoncé sa participation à la Virtual Investor Closing Bell Series le mercredi 24 juillet 2024 à 16h00 ET. Lors de cet événement, le PDG Brad Hauser présentera un aperçu de l'entreprise et des perspectives commerciales.
L'événement comportera une discussion modérée et permettra aux investisseurs de soumettre des questions en direct. Autonomix répondra à autant de questions que possible dans le temps imparti. Un webinaire vidéo en direct sera disponible sur le site web de l'entreprise, avec une rediffusion accessible pendant 90 jours après l'événement.
Autonomix Medical (NASDAQ: AMIX), ein Medizintechnikunternehmen, das sich auf innovative Technologien zur Diagnose und Behandlung von Erkrankungen des Nervensystems konzentriert, hat seine Teilnahme an der Virtual Investor Closing Bell Series am Mittwoch, den 24. Juli 2024, um 16:00 Uhr ET angekündigt. Während dieser Veranstaltung wird CEO Brad Hauser eine Unternehmensübersicht und geschäftliche Perspektiven geben.
Die Veranstaltung wird eine moderierte Diskussion umfassen und es den Investoren ermöglichen, live Fragen zu stellen. Autonomix wird so viele Fragen wie möglich innerhalb der vorgegebenen Zeit beantworten. Ein Live-Video-Webcast wird auf der Unternehmenswebsite verfügbar sein, mit einer Wiederholung, die 90 Tage nach der Veranstaltung zugänglich ist.
- None.
- None.
Live webcast on Wednesday, July 24th at 4:00 PM ET
THE WOODLANDS, TX, July 22, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that it will participate in the Virtual Investor Closing Bell Series on Wednesday, July 24, 2024 at 4:00 PM ET.
As part of the event, Brad Hauser, Chief Executive Officer of Autonomix, will provide a corporate overview and business outlook. In addition to the moderated discussion, investors and interested parties will have the opportunity to submit questions live during the event. The Company will answer as many questions as possible in the time allowed.
A live video webcast will be available on the Events page under the Investors section of the Company’s website (autonomix.com). A webcast replay will be available two hours following the live event and will be accessible for 90 days.
About Autonomix Medical, Inc.
Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate neural signals with approximately 3,000 times greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body.
We are initially developing technology for the treatment of pain, with initial trials focused on pancreatic cancer, a condition that causes debilitating pain and is without a reliable solution. Our technology constitutes a platform to address dozens of indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Our technology is investigational and has not yet been cleared for marketing in the United States.
For more information, visit autonomix.com and connect with the Company on X, LinkedIn, Instagram and Facebook.
Investor and Media Contact
JTC Team, LLC
Jenene Thomas
833-475-8247
autonomix@jtcir.com
FAQ
When is Autonomix Medical (AMIX) participating in the Virtual Investor Closing Bell Series?
Who will be presenting for Autonomix Medical (AMIX) at the Virtual Investor Closing Bell Series?
What will be discussed during Autonomix Medical's (AMIX) presentation at the Virtual Investor Closing Bell Series?
How can investors watch Autonomix Medical's (AMIX) presentation at the Virtual Investor Closing Bell Series?
Will there be a replay available of Autonomix Medical's (AMIX) Virtual Investor Closing Bell Series presentation?
